The global Liquid Biopsy Market is valued at USD 11.41 Billion in 2024 and is projected to reach a value of USD 30.65 Billion ...

Tempus AI TEM continues to push the boundaries of precision medicine through a robust pipeline of research and development (R&D) initiatives. In June, the company introduced xM, a liquid biopsy assay ...

Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

SeqOnce, a company focused on the research, development, and commercialization of qPCR and NGS genomics tools for the Infectious Disease Research & CLIA Testing Market, has launched their new Measles ...

Incyte INCY has put up a good performance in the past three months. Shares of the company have gained 9.2% against the industry’s decline of 1.3%. The stock has also outperformed the sector in the ...

Linda De Jesus, IDT Vice President and General Manager, Global Head of Commercial.

This application note outlines a comprehensive workflow for MRD detection, using a next-generation sequencing (NGS) approach ...

In the US, genome sequencing for newborns is increasing, raising ethical questions about predicting future health risks.

Combines highly complementary proteomics expertise with Illumina's industry-leading product innovation and global market reach Positions Illumina to achieve growth in a large, expanding market ...

Market is expected to reach at a CAGR of 11.6% during the forecast period 2025-2033. The Next Generation Sequencing (NGS) ...

SNS Insider Unveils Strategic Insights into the U.S. Long Read Sequencing Market's Exponential Growth-Valued at USD 220.26 Million in 2023-While the ...